Industry News

ALE Device introduces a high-end 5-inch IPS SIP DeskPhone with built-in 2.5/5G Wi-Fi and Bluetooth 5.0

Alcatel-Lucent Enterprise M8 DeskPhone: more than a phone SHANGHAI, June 7, 2022 /PRNewswire/ -- ALE China Co., Ltd, a leader in audio technology for the global landline phone market, trading under the name ofALE Device , is introducing a high-end SIP DeskPhone under i...

2022-06-07 13:13 4691

ManpowerGroup Talent Solutions Named a Star Performer and Global Leader in Recruitment Process Outsourcing by Everest Group

Recognized for Breadth and Depth of Global Service Offerings and Advances in Business Intelligence MILWAUKEE, June 7, 2022 /PRNewswire/ -- ManpowerGroup Talent Solutions (NYSE: MAN) has been named a global leader in Recruitment Process Outsourcing (RPO) for the 12th year in the Everest Group PEA...

2022-06-07 13:01 4161

GARNIER MALAYSIA KICKS OFF GARNIER GREEN BEAUTY INITIATIVE WITH PANTAI REMIS BEACH CLEANUP

KUALA LUMPUR, Malaysia, June 7, 2022 /PRNewswire/ -- Garnier Malaysia recently held its first beach clean-up at Pantai Remis in Kuala Selangor as part of its environmental initiative under its Garnier Green Beauty commitments. In 2022, Garnier Malaysia and the Malaysian Nature Society are collabo...

2022-06-07 12:23 4016

SCG Cell Therapy And A*STAR's IMCB Collaborate To Accelerate Clinical Translation of Immune Cell-based Therapy

* The collaboration agreement works toward accelerating the study of SCG's immunotherapy pipeline and candidates such as CAR-T, TCR-T therapies, antibodies, and vaccines. * SCG will contribute its proprietary technologies to the therapeutic development of immune cell-based therapy candidates....

2022-06-07 12:23 3792

Trip.com Group corporate travel arm Trip.Biz releases China market white paper as it shares global expansion strategy

SHANGHAI, June 7, 2022 /PRNewswire/ -- Trip.com Group's corporate travel arm, Trip.Biz, has released a white paper delving into the trends defining the reviving corporate travel management sector in mainlandChina. The Trip.Biz white paper sum...

2022-06-07 12:17 3498

XCMG Ranks in Top Three in KHL Group's Yellow Table for Second Consecutive Year

Its Aerial Work Platform Also Ranks 5th Position in the Access M20 Manufacturers list XUZHOU, China, June 7, 2022 /PRNewswire/ -- XCMG (SHE:000425) is ranked among the top three original equipment manufacturers (OEMs) in the world for the second consecutive year, according to the Yellow Table pu...

2022-06-07 12:00 5950

Antengene Announces HREC Approval in Australia for the Phase I Trial of the Small Molecule ATR Inhibitor ATG-018

– Discovered in-house by the internal R&D Team at Antengene, ATG-018 is an orally-bioavailable, small molecule ataxia telangiectasia and Rad3-associated (ATR) kinase inhibitor that targets the DNA damage response (DDR) pathway. – This Phase I study will evaluate the safety, pharmacology and prelim...

2022-06-07 11:34 3707

ASCO 2022 | Ascentage Pharma Releases Updated Results Demonstrating the Therapeutic Potential of Alrizomadlin (APG-115) plus Pembrolizumab in Patients with Solid Tumors who Progressed on Immunotherapies

SUZHOU, China, and ROCKVILLE, Md., June 6, 2022 /PRNewswire/ -- scentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that it has released the updated results from a Pha...

2022-06-07 11:30 2655

CapitaLand Investment acquires 22-storey office tower in Melbourne's CBD

Acquisition marks CLI's fifth investment in Australia within six months SINGAPORE, June 7, 2022 /PRNewswire/ -- CapitaLand Investment Limited (CLI) has acquired a freehold office tower in the Western Core of Melbourne's Central Business District for its flagship regional core-plus fund, Capit...

2022-06-07 11:29 4349

ASCO 2022 | The First Dataset of Olverembatinib (HQP1351) in Patients with GIST Demonstrates Therapeutic Potential with a Clinical Benefit Rate of 83.3%

SUZHOU, China, and ROCKVILLE, Md., June 6, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that it has released the latest results from a Pha...

2022-06-07 11:28 2491

IUCN and Huawei call for greater technology adoption to protect nature

Echoing the "Only One Earth" theme of World Environment Day on June 5, the International Union for Conservation of Nature (IUCN), Huawei, and global partners explored the role of technology in nature conservation at the Tech for a Better Planet summit. SHENZHEN, China, June 7, 2022 /PRNewswire/ ...

2022-06-07 10:30 9597

Tuya Smart to Present Smart Lighting Solutions at LightFair 2022

NEW YORK, June 6, 2022 /PRNewswire/ -- Tuya Smart (NYSE: TUYA), a leading IoT development platform service provider, this week announced it will participate in the LightFair 2022 Trade Show and Conference. Hosted inLas Vegas, LightFair 2022 will take placeJune 19-23, 2022 at the Las Vegas Convent...

2022-06-07 10:23 3249

Tonik boosts API security with Noname Security solution

As it revolutionizes the way money works in Southeast Asia, the neobank is strengthening a critical component of cybersecurity in an interconnected online world. SINGAPORE, June 7, 2022 /PRNewswire/ -- Noname Security , the complete proactive API security platform, ...

2022-06-07 10:00 3672

LONGi Founder and President Li Zhenguo advocates building a healthy planet for everyone's prosperity by providing clean, efficient and affordable energy at Stockholm +50 Conference

XI'AN, China, June 7, 2022 /PRNewswire/ -- This year is the 50th anniversary of the United Nations Conference on the Human Environment (1972-2022). To mark this occasion, the UN announced to convene the "Stockholm +50" High-level International Conference themed "A Healthy Planet for the Prosperit...

2022-06-07 09:33 2763

J&T Express Acquires Land in Malaysia

Investing RM 600 Million in Infrastructure  Expansion of facilities to drive development in the local economy and across the region KUALA LUMPUR, Malaysia, June 7, 2022 /PRNewswire/ -- J&T Express ("J&T"), an international express logistics company, announced today it has completed the acquisit...

2022-06-07 09:30 3278

iNtRON Completes GLP-TOX Studies of BAL200

* A novel drug candidate for anthrax received orphan drug designation (ODD) by the US FDA. BOSTON and SEOUL, Korea, June 6, 2022 /PRNewswire/ -- iNtRON Biotechnology ("iNtRON" or "Company") announced today that the company has successfully completed the GLP toxicology studies of BAL200. The co...

2022-06-07 09:00 2618

P.I. Works and VMware To Bolster O-RAN Adoption and Innovation

P.I. Works' rApps to be interoperable with VMware's Non-Real-Time RIC Platform to enable the automation and optimization of Open RAN networks RESTON, VA, June 7, 2022 /PRNewswire/ -- P.I. Works, the leading provider of AI-driven mobile network management solutions, has announced its rApps are...

2022-06-07 09:00 4516

Pharmactive Enters Strategic Partnership with Nutraconnect for APAC

Pharmactive targets Asia Pacific Market with new collaboration MADRID, June 7, 2022 /PRNewswire/ -- Pharmactive Biotech Products , S.L.U., announces a new strategic partnership withSingapore-based Nutraconnect Pte, Ltd. to bring innovative, scientifically ...

2022-06-07 09:00 3014

Prinx Chengshan unveils new flagship brand at Tire Cologne 2022 targeting global market amid EV transition

COLOGNE, Germany, June 7, 2022 /PRNewswire/ -- Prinx Chengshan, the international tire company with Chinese origin, debuted its new flagship brand PRINX at Tire Cologne 2022, fromMay 24 to 26, 2022. With an international product portfolio covering the PRINX, Chengshan, Austone and Fortune brands,...

2022-06-07 08:52 2031

CStone presents pre-specified overall survival data of sugemalimab for first-line treatment of stage IV non-small cell lung cancer at ASCO 2022

* Sugemalimab is the world's first PD-L1 monoclonal antibody to show the statistically significant and clinically meaningful overall survival improvement in combination with chemotherapy for patients with treatment-naïve stage IV non-small cell lung cancer across both squamous and non-squamous ...

2022-06-07 08:02 4412